Defective Hip Replacement Systems May Be Responsible For an Increase In Serum Metal Ion Levels

The adverse effects associated with metal-on-metal hip replacement systems has become a significant concern in the healthcare community. The potentially hazardous side effects of elevated systemic exposure to cobalt, chromium and molybdenum are of significant concern, especially following metal-on-metal hip resurfacing, standard total hip arthroplasty or any other joint replacement system involving metal components….

Read More

FDA Questions Give Insight To The Future Of Transvaginal Mesh Products

September 8-9, 2011 will witness an advisory committee of the U.S. Food and Drug Administration (FDA) convene to discuss the future of transvaginal mesh products. The Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee hopes to present the FDA with substantial evidence pertaining to the use of transvaginal mesh. However, the…

Read More

Abnormal Heart Rhythms Associated With High Doses of Celexa

Healthcare officials at the U.S. Food and Drug Administration (FDA) have recently acknowledged new dangers associated with one of the world’s most popular antidepressants. Recent studies suggest that Celexa (citalopram hydrobromide), a selective serotonin reuptake inhibitor (SSRI), may be responsible for patients developing abnormal electrical activity in their heart. Doses larger than 40 mg…

Read More

Roster Set For Upcoming Transvaginal Mesh Advisory Committee

An influx of adverse transvaginal mesh reports have become the subject of intense scrutiny in the healthcare community. The past two years have witnessed an exponential growth in complications associated with the surgical application of transvaginal mesh products. Due to the frequency and severity in which these adverse events are being reported, a public…

Read More

Cook Biotech Inc. Urges The FDA To Consider New Information When Deliberating Vaginal Mesh Recommendations

In response to the upcoming advisory committee, scheduled to meet on September 8-9, Cook Biotech Incorporated has submitted information to be considered by the U.S. Food and Drug Administration (FDA) regarding the safety and effectiveness of transvaginal mesh products used in the treatment of pelvic organ prolapse (POP). An influx of adverse transvaginal mesh…

Read More

Settlement Leads to Label Changes on Brazilian Blowout Products

As a relatively new hair treatment, Brazilian Blowout boasts the ability to straighten hair, while simultaneously creating a protective and nutrient rich barrier around it. However, critics of the revolutionary hair treatment product have revealed a potentially dangerous and undisclosed mechanism of action. When introduced to direct heat, the product releases formaldehyde gas. Inhalation…

Read More

Guillain-Barré Syndrome Lawyer & Lawsuit

Guillain-Barré Syndrome is an uncommon disorder in which a person’s immune system attacks their nerves. Symptoms can spread throughout the entire body over time and lead to complete paralysis. In this article we will discuss the signs and symptoms, causes, risk factors, complications, tests and diagnosis for Guillain-Barré Syndrome. If you or a loved…

Read More

Popcorn Lung Lawsuit

Popcorn lung, otherwise known as bronchiolitis obliterans, is a rare and potentially life-threatening variation of non-reversible obstructive lung disease. Of significant concern, however, are recent reports that have established an association between this condition and the inhalation of diacetyl; a chemical used to produce the butter-like flavoring in many foods such as candy, microwave…

Read More